INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 79 filers reported holding INSTIL BIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,344,345 | -22.3% | 12,486,787 | 0.0% | 0.59% | +23.4% |
| Q2 2023 | $6,880,220 | -16.6% | 12,486,787 | 0.0% | 0.48% | -17.1% |
| Q1 2023 | $8,251,269 | +104784.6% | 12,486,787 | 0.0% | 0.57% | -36.8% |
| Q4 2022 | $7,867 | -100.0% | 12,486,787 | 0.0% | 0.91% | -86.4% |
| Q3 2022 | $60,436,000 | +4.8% | 12,486,787 | 0.0% | 6.67% | +15.2% |
| Q2 2022 | $57,689,000 | -57.0% | 12,486,787 | 0.0% | 5.79% | -37.3% |
| Q1 2022 | $134,233,000 | -37.2% | 12,486,787 | 0.0% | 9.24% | -28.2% |
| Q4 2021 | $213,649,000 | -4.3% | 12,486,787 | 0.0% | 12.88% | +28.5% |
| Q3 2021 | $223,201,000 | -7.5% | 12,486,787 | 0.0% | 10.02% | -4.0% |
| Q2 2021 | $241,245,000 | -23.0% | 12,486,787 | 0.0% | 10.44% | -5.1% |
| Q1 2021 | $313,169,000 | – | 12,486,787 | – | 11.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $183,824,000 | 100.00% |
| CPMG Inc | 8,218,467 | $39,777,000 | 7.80% |
| Vivo Capital, LLC | 12,486,787 | $60,436,000 | 6.67% |
| VR Adviser, LLC | 4,105,779 | $19,872,000 | 3.07% |
| Samsara BioCapital, LLC | 1,788,280 | $8,655,000 | 2.02% |
| Parametrica Management Ltd | 88,263 | $428,000 | 0.88% |
| RA Capital Management | 7,670,793 | $37,127,000 | 0.79% |
| Fairmount Funds Management LLC | 673,905 | $3,262,000 | 0.57% |
| Nicholas Investment Partners, LP | 897,386 | $4,343,000 | 0.40% |
| Logos Global Management LP | 331,872 | $1,606,000 | 0.20% |